Literature DB >> 23872721

Reactive oxygen species in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease.

Mindaugas Vaitkus1, Simona Lavinskiene, Diana Barkauskiene, Kristina Bieksiene, Jolanta Jeroch, Raimundas Sakalauskas.   

Abstract

Chronic airway inflammation can be mediated by an enhanced neutrophil oxidative burst. However, the role of bacteria in the pathogenesis of chronic obstructive pulmonary disease (COPD) exacerbations is highly controversial. The aim of this study was to evaluate the production of reactive oxygen species (ROS) in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbations of COPD (AECOPD). A total of 40 patients with AECOPD, 10 healthy nonsmokers, and 10 "healthy" smokers were enrolled into the study. Peripheral blood and sputum samples were obtained during exacerbation and after recovery. Neutrophils were isolated by high-density gradient centrifugation and magnetic separation. ROS production by neutrophils was investigated after stimulation with phorbol-myristate-acetate and Staphylococcus aureus bacteria. ROS production by neutrophils was assessed as the mean fluorescent intensity using a flow cytometer. IL-8 levels in serum and induced sputum were determinant by ELISA. Spontaneous ROS production was significantly higher in neutrophils from the patients with bacterial AECOPD as compared with nonbacterial AECOPD and stable COPD (P <0.05). ROS production stimulated with PMA and with Staphylococcus aureus was significantly higher in neutrophils isolated from the patients with bacterial AECOPD as compared with nonbacterial and stable COPD (P <0.05). The serum and induced sputum IL-8 levels were significantly increased in the patients with bacterial AECOPD than nonbacterial AECOPD, stable COPS, and "healthy" smokers and nonsmokers (P <0.05) and higher in the induced sputum as the compared with serum in all studied groups (P <0.05). Enlarge CRP level was documented during AECOPD than in all other groups (P <0.05). A markedly increased ROS production in sputum neutrophils during bacterial AECOPD shows an inflammatory response reflecting enhanced local inflammation, which can be mediated by bacterial colonization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23872721     DOI: 10.1007/s10753-013-9690-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  38 in total

Review 1.  The macrophage in chronic obstructive pulmonary disease.

Authors:  S D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

2.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

3.  Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers.

Authors:  S Salvi; A Blomberg; B Rudell; F Kelly; T Sandström; S T Holgate; A Frew
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

4.  Increased exhalation of hydrogen peroxide in healthy subjects following cigarette consumption.

Authors:  S B Guatura; J A Martinez; P C Santos Bueno; M L Santos
Journal:  Sao Paulo Med J       Date:  2000-07-06       Impact factor: 1.044

5.  Smoke and C5a induce airway epithelial intercellular adhesion molecule-1 and cell adhesion.

Authors:  Anthony A Floreani; Todd A Wyatt; Julie Stoner; Sam D Sanderson; Ethan G Thompson; Diane Allen-Gipson; Art J Heires
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04-24       Impact factor: 6.914

6.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 7.  ROS in the local and systemic pathogenesis of COPD.

Authors:  R C J Langen; S H Korn; E F M Wouters
Journal:  Free Radic Biol Med       Date:  2003-08-01       Impact factor: 7.376

8.  C-reactive protein--can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?

Authors:  Nina Weis; Thomas Almdal
Journal:  Eur J Intern Med       Date:  2006-03       Impact factor: 4.487

Review 9.  Systemic inflammation in chronic obstructive pulmonary disease.

Authors:  E J D Oudijk; J W J Lammers; L Koenderman
Journal:  Eur Respir J Suppl       Date:  2003-11

10.  Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells.

Authors:  Gary R Hellermann; Szilvia B Nagy; Xiaoyuan Kong; Richard F Lockey; Shyam S Mohapatra
Journal:  Respir Res       Date:  2002-07-10
View more
  8 in total

1.  Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism.

Authors:  Qiong-Fang Yang; Ting-Ting Lu; Cai-Min Shu; Lan-Fang Feng; Hao-Teng Chang; Qiao-Ying Ji
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

2.  Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.

Authors:  George Hoult; David Gillespie; Tom M A Wilkinson; Mike Thomas; Nick A Francis
Journal:  BMC Pulm Med       Date:  2022-05-13       Impact factor: 3.320

3.  Impaired Blood Neutrophil Function in the Frequent Exacerbator of Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study.

Authors:  Arwel Wyn Jones; Richard Robinson; Peer Mohamed; Glen Davison; Hassan Jaysen Izzat; Keir Edward Lewis
Journal:  Lung       Date:  2016-08-16       Impact factor: 2.584

Review 4.  Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?

Authors:  Georgia M Walton; James A Stockley; Diane Griffiths; Charandeep S Sadhra; Thomas Purvis; Elizabeth Sapey
Journal:  J Clin Med       Date:  2016-10-11       Impact factor: 4.241

5.  Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression.

Authors:  Ravi Lokwani; Peter Ab Wark; Katherine J Baines; Michael Fricker; Daniel Barker; Jodie L Simpson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-15

Review 6.  Combined Antioxidant, Anti-inflammaging and Mesenchymal Stem Cell Treatment: A Possible Therapeutic Direction in Elderly Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Shijin Xia; Changxi Zhou; Bill Kalionis; Xiaoping Shuang; Haiyan Ge; Wen Gao
Journal:  Aging Dis       Date:  2020-02-01       Impact factor: 6.745

7.  Ebselen abolishes vascular dysfunction in influenza A virus-induced exacerbations of cigarette smoke-induced lung inflammation in mice.

Authors:  Kurt Brassington; Stanley M H Chan; Simone N De Luca; Aleksandar Dobric; Suleman A Almerdasi; Kevin Mou; Huei Jiunn Seow; Osezua Oseghale; Steven Bozinovski; Stavros Selemidis; Ross Vlahos
Journal:  Clin Sci (Lond)       Date:  2022-04-29       Impact factor: 6.876

8.  Inference of Cellular Immune Environments in Sputum and Peripheral Blood Associated with Acute Exacerbations of COPD.

Authors:  Katy C Norman; Christine M Freeman; Neha S Bidthanapally; MeiLan K Han; Fernando J Martinez; Jeffrey L Curtis; Kelly B Arnold
Journal:  Cell Mol Bioeng       Date:  2019-03-15       Impact factor: 2.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.